Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Magdalena G, Krzystolik"'
Publikováno v:
Journal of Pediatric Ophthalmology & Strabismus. 58:377-384
Purpose: To examine the incidence and initial presentation of sports-related ocular injury in youth. Methods: This retrospective case series study was performed at Massachusetts Eye and Ear, Boston, Massachusetts. Inclusion criteria were visit dates
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe49f986e1b827794f0f0a8a968beac4
https://doi.org/10.3928/01913913-20210423-02
https://doi.org/10.3928/01913913-20210423-02
Publikováno v:
The Journal of Emergency Medicine
Background Coronavirus disease-2019 (COVID-19), caused by a novel coronavirus termed severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has been linked to ocular signs and symptoms in several case reports. Research has demonstrated that SA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d3dccc48baeb0d873a6e574b5174ba8
https://doi.org/10.1016/j.jemermed.2020.04.060
https://doi.org/10.1016/j.jemermed.2020.04.060
Publikováno v:
Rhode Island medical journal (2013). 103(8)
To determine the most commonly used and highest-rated mobile applications (apps) for low-vision aids.This was a convenience sample survey. Patients known to use low-vision apps at a nonprofit low-vision center (INSIGHT, Warwick, RI) were contacted by
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::58a11d8c40ff0529e4038c250ca8ee5d
https://pubmed.ncbi.nlm.nih.gov/33003684
https://pubmed.ncbi.nlm.nih.gov/33003684
Publikováno v:
The Cochrane Library
Cochrane Database Syst Rev
Cochrane Database Syst Rev
Background Age-related macular degeneration (AMD) is one of the leading causes of permanent blindness worldwide. The current mainstay of treatment for neovascular AMD (nAMD) is intravitreal injection of anti-vascular endothelial growth factor (anti-V
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1423ce297750c1eccb9a459233c2a4be
https://doi.org/10.1002/14651858.cd012208.pub2
https://doi.org/10.1002/14651858.cd012208.pub2
Publikováno v:
Graefe's Archive for Clinical and Experimental Ophthalmology. 253:1619-1621
Dear Editor: The growing elderly population and prevalence of diabetes mellitus have increased the number of patients with exudative age-related macular degeneration (AMD) and diabetic macular edema (DME) [1–4]. This has created a need to explore m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5f8837e30cc785f2af75929cdf184dc
https://doi.org/10.1007/s00417-014-2921-y
https://doi.org/10.1007/s00417-014-2921-y
Publikováno v:
Rhode Island medical journal (2013). 99(5)
Anti-vascular endothelial growth factor (anti-VEGF) drugs - ranibizumab, aflibercept, and off-label bevacizumab - are vital to the treatment of common retinal diseases, including exudative age-related macular degeneration (AMD), diabetic macular edem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::25ac4b14c5faed5619279a70e3c7969b
https://pubmed.ncbi.nlm.nih.gov/27128510
https://pubmed.ncbi.nlm.nih.gov/27128510
Autor:
Janis Graul, Craig N. Kelso, Dennis B. Backes, Paul G. Arrigg, Collin L. DuCoty, John M. Bourg, David Emmert, Caldwell W. Smith, Helen K. Li, Ann Kopple, Robert H. Janigian, Terri Cain, Brian A. Rusinek, Donna J. Chesbrough, Susan Rath, Jennifer V. Helms, Michael J. Elman, Joe Fischer, Sheila M. Rock, Jo Ann Starr, Erika Banalewicz, Michelle Buck, Manjot K. Gill, Peter Sotirakos, Teresa Coffey, Paul M. Beer, Debbie M. Brown, David J. Browning, Judy E. Kim, Amy M. Flowers, Laima M. O'Donnell, Stephen T. Blevins, Giorya Shabi Andreani, Sylvia Varadian, Michele Melia, Charisse Whitney, Garvin H. Davis, Linda M. Davis, Allen McKinney, Susan B. Bressler, James L. Kinyoun, Michele E. Powers, Happy Spillar, Mary B. Savell, Jeanette Graf, Thomas W. Stone, Kenneth M. Huff, Janet Murphy, Judith L. Cruz, John W. Kitchens, Deborah K. Schlossman, Sandra U. Castillo, William J. Wood, Jeanne Van Arsdall, Roy W. Beck, Stacy Carpenter, Alex L. Nagle, Sandra Henriques, Jeffrey G. Gross, Edward A. Slade, Andrew N. Antoszyk, Heather L. Murphy, Joseph M. Googe, Harold A. Woodcome, Kelly A. Blackmer, Michelle D. Sloan, Jennifer K. Sun, Randall L. Price, Jon M. Braverman, Heidi K. Lovit, Timothy J. Murtha, Christina T. Higdon, Angella S. Karow, Adam R. Glassman, Julie P. Berry, Alice T. Lyon, Deborah Donohue, Loraine Clark, S. Shah, Joseph R. Beringer, Janelle Dane Zapata, Michael D. McOwen, Jonathan Shankle, Robert W. Cavicchi, Kimberly S. Walther, Eugenia Olmeda, Melissa K. Cowen, Joanne E. Bache, Leif S. Ryman, James D. Leslie, Denise Garza, Dennis P. Han, Karen Sjoblom, Margaret E. Stockman, Howard L. Cummings, Dawn Alvarez, Uma M. Balasubramaniam, Tracy A. Troszak, Brad C. Clifton, Paul A. Blais, Mary Frey, Paul A. Edwards, William J. Wirostko, Rosemary C. Rhodes, Clement K. Chan, Danielle R. Brooks, Theresa M. Butcher, K. M. Miller, Scott M. Friedman, Sasha I. Montalvo, Amber Crocker, Pamela V. Singletary, Sharon D. Solomon, Steve Carlton, Jolleen S. Key, Dawn M. Ryan, S. B. Bressler, L. Kaminski, Deanna Jo Long, Nancy Gore, Donna McClain, Magdalena G. Krzystolik, George S. Sharuk, Angela K. Price, Cecile Hunt, Antonio P. Ciardella, Lori E. Ackatz, Mark Hamel, Sandra West, Neil M. Bressler, Damanda A. Fagan, Judy Flanders
Publikováno v:
Eye. 26:833-840
To determine the rate of progression of eyes with subclinical diabetic macular edema (DME) to clinically apparent DME or DME necessitating treatment during a 2-year period. In all, 43 eyes from 39 study participants with subclinical DME, defined as a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35a1afcd024c57cc461fb544dd3a7bcb
https://doi.org/10.1038/eye.2012.53
https://doi.org/10.1038/eye.2012.53
Autor:
Jeffrey G. Gross, R. P. Danis, Judy E. Kim, David J. Browning, Adam R. Glassman, Strauber Sf, Victor H. Gonzalez, Roy W. Beck, Craig Kollman, Neil M. Bressler, Lloyd Paul Aiello, Chambers Rb, Brian B. Berger, Davis, Paul B. Greenberg, Magdalena G. Krzystolik
Publikováno v:
Ophthalmology. 114:1520-1525
To evaluate optical coherence tomography (OCT) reproducibility in patients with diabetic macular edema (DME).Prospective 1-day observational study.Two hundred twelve eyes of 107 patients with DME involving the macular center by clinical examination a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05e78cae11ad20f6cffeb3a73740d777
https://doi.org/10.1016/j.ophtha.2006.10.055
https://doi.org/10.1016/j.ophtha.2006.10.055
Autor:
Sharon D, Solomon, Kristina B, Lindsley, Magdalena G, Krzystolik, Satyanarayana S, Vedula, Barbara S, Hawkins
Publikováno v:
Ophthalmology. 123(1)
To summarize the relative effects of bevacizumab (Avastin; Genentech, Inc, South San Francisco, CA) and ranibizumab (Lucentis; Genentech, Inc.), using findings from a Cochrane Eyes and Vision Group systematic review.Neovascular age-related macular de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b63d9cc44cda22725a4701a7c3f82500
https://pubmed.ncbi.nlm.nih.gov/26477843
https://pubmed.ncbi.nlm.nih.gov/26477843